• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症与粪便微生物群移植:你打算吃那个吗?

Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?

机构信息

1 University of Western Ontario, 339 Windermere Rd, London, ON N6A 5A5, Canada.

出版信息

Benef Microbes. 2019 Feb 8;10(1):27-32. doi: 10.3920/BM2018.0029. Epub 2018 Dec 10.

DOI:10.3920/BM2018.0029
PMID:30525949
Abstract

Gut microbiome interaction goes beyond commensal function as vitamin production or support nutrients digestion. It also interplays with the host immune system and may be related to the development of immune-mediated diseases. Multiple sclerosis patients have dysbiosis compared to healthy individuals. But how this relates to disease development and severity is still uncertain. Dietary change including probiotic mixtures or ketogenic regimen has proven to change microbiome in multiple sclerosis (MS) subjects to one similar to healthy controls. However, proof of clinical benefits is lacking. We dissert on current knowledge about immune system and gut bacteria interactions. We discuss faecal microbial transplantation as a potential intervention to ameliorate gut dysbiosis in MS as well as the caveats of a clinical trial design.

摘要

肠道微生物组的相互作用不仅限于产生维生素或支持营养物质消化的共生功能。它还与宿主免疫系统相互作用,可能与免疫介导性疾病的发展有关。与健康个体相比,多发性硬化症患者存在肠道菌群失调。但是,这种情况与疾病的发展和严重程度有何关系仍不确定。饮食改变,包括益生菌混合物或生酮饮食,已被证明可使多发性硬化症(MS)患者的微生物组发生变化,使其类似于健康对照组。然而,缺乏临床获益的证据。我们论述了免疫系统和肠道细菌相互作用的现有知识。我们讨论了粪便微生物移植作为改善多发性硬化症肠道菌群失调的一种潜在干预措施,以及临床试验设计的注意事项。

相似文献

1
Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?多发性硬化症与粪便微生物群移植:你打算吃那个吗?
Benef Microbes. 2019 Feb 8;10(1):27-32. doi: 10.3920/BM2018.0029. Epub 2018 Dec 10.
2
Gut microbiome in multiple sclerosis: The players involved and the roles they play.多发性硬化症中的肠道微生物组:涉及的角色及其作用。
Gut Microbes. 2017 Nov 2;8(6):607-615. doi: 10.1080/19490976.2017.1349041. Epub 2017 Aug 3.
3
Gut microbiota in autoimmunity: potential for clinical applications.自身免疫中的肠道微生物群:临床应用潜力
Arch Pharm Res. 2016 Nov;39(11):1565-1576. doi: 10.1007/s12272-016-0796-7. Epub 2016 Jul 22.
4
[Intestinal immune response is regulated by gut microbe].肠道免疫反应受肠道微生物调节。
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):408-415. doi: 10.2177/jsci.40.408.
5
Intestinal dysbiosis and probiotic applications in autoimmune diseases.肠道菌群失调与益生菌在自身免疫性疾病中的应用
Immunology. 2017 Sep;152(1):1-12. doi: 10.1111/imm.12765. Epub 2017 Jun 29.
6
Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?肠道微生物群和益生菌:重症肌无力的新型免疫系统调节剂?
Ann N Y Acad Sci. 2018 Feb;1413(1):49-58. doi: 10.1111/nyas.13567. Epub 2018 Jan 17.
7
The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.克罗恩病中的微生物组:在发病机制中的作用和微生物组替代疗法的作用。
Gastroenterol Clin North Am. 2017 Sep;46(3):481-492. doi: 10.1016/j.gtc.2017.05.004. Epub 2017 Jul 19.
8
Gut environmental factors and multiple sclerosis.肠道环境因素与多发性硬化症。
J Neuroimmunol. 2019 Apr 15;329:20-23. doi: 10.1016/j.jneuroim.2018.07.015. Epub 2018 Jul 27.
9
Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?治疗肠道微生物群是改善肝硬化治疗效果的关键吗?
Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):1-2. doi: 10.1080/17474124.2019.1543587. Epub 2018 Nov 13.
10
Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?老年人群肠道菌群失调及相关疾病的治疗干预:抗生素、益生菌还是粪便微生物移植?
Benef Microbes. 2017 Apr 26;8(2):179-192. doi: 10.3920/BM2016.0115. Epub 2016 Dec 23.

引用本文的文献

1
Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.微生物组-大脑通讯对神经炎症和神经退行性变的影响。
Int J Mol Sci. 2023 Oct 5;24(19):14925. doi: 10.3390/ijms241914925.
2
The Application of High-Throughput Technologies for the Study of Microbiome and Cancer.高通量技术在微生物组与癌症研究中的应用
Front Genet. 2021 Jul 28;12:699793. doi: 10.3389/fgene.2021.699793. eCollection 2021.
3
Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.调节肠道微生物群:多发性硬化症预防和治疗的新方法。
Curr Neuropharmacol. 2021;19(11):1966-1983. doi: 10.2174/1570159X19666210217084827.
4
The Core of Gut Life: Profile in Patients with Relapsing-Remitting Multiple Sclerosis.肠道生命的核心:复发缓解型多发性硬化症患者的概况
Life (Basel). 2021 Jan 14;11(1):55. doi: 10.3390/life11010055.
5
The progress of gut microbiome research related to brain disorders.肠道微生物组与脑疾病相关研究进展。
J Neuroinflammation. 2020 Jan 17;17(1):25. doi: 10.1186/s12974-020-1705-z.
6
Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity.俄罗斯队列中的原发性进行性多发性硬化症:与肠道细菌多样性的关系。
BMC Microbiol. 2019 Dec 30;19(1):309. doi: 10.1186/s12866-019-1685-2.
7
Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice.汉防己甲素平衡肠道微生物群并逆转 APP/PS1 转基因小鼠的学习和记忆缺陷。
Sci Rep. 2019 Dec 20;9(1):19575. doi: 10.1038/s41598-019-56149-9.